NERV 8-K 2026-11-06

Minerva Neurosciences, Inc. (NERV) 8-K dated 2026-11-06 — accession 0001193125-26-450877.

Minerva Neurosciences, Inc. (NERV) is a biotechnology company listed on US.

NERV: Minerva Neurosciences Provides Third Quarter 2026 Financial Results

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported NERV revenue for 2024-12-31 was $0. Net income was $1.4M. NERV currently screens at market cap $12.4M.

Not investment advice. The NERV SEC hub lists recent forms. The stock page is the research view.